These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34837441)
41. Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes. Silva-Rojas R; Nattarayan V; Jaque-Fernandez F; Gomez-Oca R; Menuet A; Reiss D; Goret M; Messaddeq N; Lionello VM; Kretz C; Cowling BS; Jacquemond V; Laporte J Mol Ther; 2022 Feb; 30(2):868-880. PubMed ID: 34371181 [TBL] [Abstract][Full Text] [Related]
42. A rare case of centronuclear myopathy with Aghbolaghi AG; Lechpammer M Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838 [TBL] [Abstract][Full Text] [Related]
43. Mutations in dynamin 2 cause dominant centronuclear myopathy. Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997 [TBL] [Abstract][Full Text] [Related]
44. Centronuclear myopathies: a widening concept. Romero NB Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480 [TBL] [Abstract][Full Text] [Related]
46. Clinical, Electrophysiology, and Pathology Features of Dynamin Centronuclear Myopathy: A Case Report and Review of Literature. Verma S; Balasubramanian SB J Clin Neuromuscul Dis; 2016 Dec; 18(2):84-88. PubMed ID: 27861221 [TBL] [Abstract][Full Text] [Related]
47. DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy. Abath Neto O; Martins Cde A; Carvalho M; Chadi G; Seitz KW; Oliveira AS; Reed UC; Laporte J; Zanoteli E Genet Mol Biol; 2015 May; 38(2):147-51. PubMed ID: 26273216 [TBL] [Abstract][Full Text] [Related]
48. Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease. Zhao M; Maani N; Dowling JJ Neurotherapeutics; 2018 Oct; 15(4):966-975. PubMed ID: 30426359 [TBL] [Abstract][Full Text] [Related]
49. Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model. Li Q; Lin J; Widrick JJ; Luo S; Li G; Zhang Y; Laporte J; Perrella MA; Liu X; Agrawal PB JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35763354 [TBL] [Abstract][Full Text] [Related]
50. A novel dynamin-2 gene mutation associated with a late-onset centronuclear myopathy with necklace fibres. Casar-Borota O; Jacobsson J; Libelius R; Oldfors CH; Malfatti E; Romero NB; Oldfors A Neuromuscul Disord; 2015 Apr; 25(4):345-8. PubMed ID: 25633151 [TBL] [Abstract][Full Text] [Related]
51. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases. Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864 [TBL] [Abstract][Full Text] [Related]
52. Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy. Espinosa KG; Geissah S; Groom L; Volpatti J; Scott IC; Dirksen RT; Zhao M; Dowling JJ Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35293586 [TBL] [Abstract][Full Text] [Related]
53. Respiratory features of centronuclear myopathy in the Netherlands. Bouma S; Cobben N; Bouman K; Gaytant M; van de Biggelaar R; van Doorn J; Reumers SFI; Voet NB; Doorduin J; Erasmus CE; Kamsteeg EJ; Jungbluth H; Wijkstra P; Voermans NC Neuromuscul Disord; 2023 Jul; 33(7):580-588. PubMed ID: 37364426 [TBL] [Abstract][Full Text] [Related]
54. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation. Romero NB; Bevilacqua JA; Oldfors A; Fardeau M Neuromuscul Disord; 2011 Feb; 21(2):148; author reply 148-9. PubMed ID: 21247764 [No Abstract] [Full Text] [Related]
55. Impaired excitation-contraction coupling in muscle fibres from the dynamin2 Kutchukian C; Szentesi P; Allard B; Trochet D; Beuvin M; Berthier C; Tourneur Y; Guicheney P; Csernoch L; Bitoun M; Jacquemond V J Physiol; 2017 Dec; 595(24):7369-7382. PubMed ID: 29071728 [TBL] [Abstract][Full Text] [Related]
56. DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy. de Carvalho Neves J; Moschovaki-Filippidou F; Böhm J; Laporte J Mol Ther Nucleic Acids; 2023 Sep; 33():321-334. PubMed ID: 37547294 [TBL] [Abstract][Full Text] [Related]